16
Central Nervous System
13. Tyler KL. Update on herpes simplex
encephalitis.
Rev Neurol Dis
2004;1(4):169-178.
14. Cinque P, Vago L, Terreni MR, et al. Diag-
nosis of cytomegalovirus infection of the
nervous system in AIDS by polymerase
chain reaction analysis of cerebrospinal
fluid.
Scand J Infect Dis Suppl
1995;99:
92-94.
15. Wildemann B, Haas J, Lynen N, et al.
Diagnosis of cytomegalovirus encepha-
litis in patients with AIDS by quantita-
tion of cytomegalovirus genomes in
cells of cerebrospinal fluid.
Neurology
1998;50(3):693-697.
16. Wilber RR, King EB, Howes EL. Jr
Cerebrospinal fluid in five patients
with cerebral cysticercosis.
Acta Cytol
1980;24:421-426.
17. Razavi-Encha F, Fleury-Feith J, Gherandi
R, et al. Cytologic features of cerebros-
pinal fluid in Lyme disease.
Acta Cytol
1987;31:439-440.
18. Fetter BF, Klintworth GK, Hendry WS.
Mycoses of the Central Nervous System.
Baltimore: Williams and Williams,
1967:131.
19. Saigo P, Rosen PP, Kaplan MH, et al.
Identification of
Cryptococcus neoformans
in cytologic preparations of cerebrospinal
fluid.
Am J Clin Pathol
1977;67:141-145.
20. Bigner SH. Cytologic diagnosis of cryp-
tococcal meningitis. American Society
of Clinical Pathologists check sample.
Cytopathology
1983;11:1-5.
21. Williamson JD, Silverman JF, Mallak CT,
et al. Atypical cytomorphologic appear-
ance of
Cryptococcus neoformans:
a report
of five cases.
Acta Cytol
1996;40(2):
363-370.
22. Noronha A, Richman DP, Arnason GW.
Multiple sclerosis: Activated cells in cer-
ebrospinal fluid in acute exacerbations.
Ann Neurol
1985;18:722-725.
23. Salmaggi A, LaMantia L, Milanese C, et al.
CSF T-cell subsets in multiple sclerosis:
relationships to cerebrospinal fluid
myelin basic protein and clinical activity.
J Neurol
1989;236(6):336-339.
24. Santoli D, DeFreitas EC, Sandberg-
Wollheim M, et al. Phenotypic and
functional characterization of T cell
clones derived from the cerebrospinal
fluid of multiple sclerosis patients.
Am
Assoc Immunol
1984;132:2386-2391.
25. Polman CH, de Groot CJA, Koestsier JC,
et al. Cerebrospinal fluid cells in multiple
sclerosis and other neurological diseases:
An immunocytochemical study.
J Neurol
1987;234:19-22.
26. Bigner SH, Elmore PD, Dee AL, et al.
Unusual presentations of inflammatory
conditions in cerebrospinal fluid.
Acta
Cytol
1985;29:291-296.
27. Bigner SH, Elmore PD, Dee AL, et al. The
cytopathology of reactions to ventricular
shunts.
Acta Cytol
1985;29:391-396.
28. Tzvetanova eM, Tzekov CT. Eosinophilia
in the cerebrospinal fluid of children
with shunts implanted for the treatment
of internal hydrocephalus.
Acta Cytol
1986;30:277-280.
29. Wiersbitzky SK, Ahrens N, Becker T, et al.
The diagnostic importance of eosinophil
granulocytes in the CSF of children with
ventricular-peritoneal shunt systems.
Acta
Neurol Scand
1998;97(3):201-203.
30. Belasco JB, Goldwein JW. Simms, et al.
Hypofractionated moderate dose
radiation, intrathecal chemotherapy,
and repetitive reinduction/reconsolida-
tion systemic therapy for central nervous
system relapse of acute lymphoblastic
leukemia in children.
Med Pediatr Oncol
2000;34(2):125-131.
31. Dahl GV, Simone JV, Hustu HO, et
al. Preventive central nervous system
irradiation in children with acute
nonlymphocytic leukemia.
Cancer
1978;42:2187-2192.
32. Evans AE, Gilbert ES, Zandstra R.
The increasing incidence of central
nervous system leukemia in children
(Children's Cancer Study Group A).
Cancer
1970;26:404-409.
33. Hustu HO, Aur RJA, Verzosa MS, et al.
Prevention of central nervous sys-
tem leukemia by irradiation.
Cancer
1973;32:585-597.
34. Homans AC, Forman EN, Baker BE. Use
of monoclonal antibodies to identify cer-
ebrospinal fluid lymphocytes in children
with acute lymphoblastic leukemia.
Blood
1985;66:1321-1325.
35. Ricevuti G, Savoldi F, Piccolo G, et
al. Meningeal leukemia diagnosed by
cytocentrifuge study of cerebrospinal
fluid: A study of 631 cerebrospinal fluid
samples from 87 patients.
Arch Neurol
1986;43:466-470.
36. Pine SR, Yin C, Matloub YH, et al. Detec-
tion of central nervous system leukemia
in children with acute lymphoblastic
leukemia by real-time polymerase chain
reaction.
J Mol Diagn
2005;7(1):127-132.
37. Veerman AJP, Hismans LDR, Van
Zantwijk ICH. Diagnosis of meningeal
leukemia using immunoperoxidase
methods to demonstrate common acute
lymphoblastic leukemia cells in cerebro-
spinal fluid.
Leukemia Res
1985;9:1195-
1200.
38. McIntosh S, Ritchey AK. Diagnostic prob-
lems in cerebrospinal fluid of children
with lymphoid malignancies.
Am J Pediatr
Hematol Oncol
1987;8:28-31.
39. Meyer RJ, Ferreira PPC, Cuttner JG, et al:
Central nervous system involvement at
presentation in acute granulocytic leuke-
mia, a prospective cytocentrifuge study.
Am J Med
1980;68:691-694.
40. Akintola-Ogunremi O, Whitney C,
Mathur SC, et al. Chronic lymphocytic
leukemia presenting with symptomatic
central nervous system involvement.
Ann
Hematol
2002;81(7):402-404. Epub 2002
Jun 13.
41. Brick WG, Majmundar M, Hendricks LK,
et al. Leukemic leptomeningeal involve-
ment in stage 0 and stage 1 chronic
lymphocytic leukemia.
Leuk Lymphoma
2002;43(1):199-201.
42. Getaz EP, Miller GJ. Spinal cord involve-
ment in chronic lymphocytic leukemia.
Cancer
1979;43:1858-1861.
43. Moser RP, Robinson JA, Prostko
ER: Lymphocyte subpopulations in
human cerebrospinal fluid.
Neurology
1976;26:726-728.
44. Svenningsson A, Anderson O, Edsbagge
M, et al. Lymphocyte phenotype and sub-
set distribution in normal cerebrospinal
fluid.
J Neuroimmunol
1995;63(1):
39-46.
45. Knowles DM. Immunophenotypic and
antigen receptor gene rearrangement
analysis in T-cell neoplasia.
Am J Pathol
1989;134:761-785.
46. Chhieng DC, Elgert P, Cohen JM, et al:
Cytology of primary central nervous
system neoplasms in cerebrospinal
fluid specimens.
Diagn Cytopathol
2002;26(4):209-212.
47. Glass JP, Melamed MR, Chernik NL, et al.
Malignant cells in cerebrospinal fluid
(CSF). The meaning of a positive CSF
cytology.
Neurology
1979;29:1369-1375.
48. Bigner Sh, Johnston WW. The cytopa-
thology of cerebrospinal fluid. A review.
Part II. Metastatic cancer, meningeal
carcinomatosis and primary central
nervous system neoplasms.
Acta Cytol
1981;25:461-480.
49. Bigner SH, Johnston WW. The diagnostic
challenge of tumors manifested initially
by the shedding of cells into cerebro-
spinal fluid.
Acta Cytol
1984;28:29-36.
50. Ehya H, Hajdu SL, Melamed MR. Cytopa-
thology of nonlymphoreticular neo-
plasms metastatic to the central nervous
system.
Acta Cytol
1981;25:599-610.
51. Little JR, Dale ADJ, Okazaki H. Meningeal
carcinomatosis: clinical manifestations.
Arch Neurol
1974;30:138-143.
52. Olson ME, Chernik NL, Posner JB. Infil-
tration of the leptomeninges by systemic
cancer: A clinical and pathological study.
Arch Neurol
1974;30:122-137.
53. Weed JC Jr, Creasman WT. Meningeal
carcinomatosis secondary to advanced
squamous cell carcinoma of the cervix: A
case report.
Gynecol Oncol
1975;3:
201-204.
54. Amer MH, Al-Sarraf M, Baker LH, et al.
Malignant melanoma and central
nervous system metastases: Incidence,
diagnosis, treatment and survival.
Cancer
1978;42:660-668.
55. Schmidt P, Neuen-Jacob E, Blanke M, et
al. Primary malignant melanoblastosis
of the meninges. Clinical, cytologic and
neuropathologic findings in a case.
Acta
Cytol
1988;32:713-717.
56. Ordonez NG, Sneige N, Hickey RC, et al.
Use of monoclonal antibody HMB-45
in the cytologic diagnosis of melanoma.
Acta Cytol
1988;32:684-688.
57. Pelosi G, Bonetti F, Colombari R, et al.
Use of monoclonal antibody HMB-45
for detecting malignant melanoma cells
in fine needle aspiration biopsy samples.
Acta Cytol
1990;34(3):460-462.
58. Shoup SA, Johnston WW, Seigler HF,
et al. A panel of antibodies useful in
the cytologic diagnosis of metastatic
melanoma.
Acta Cytol
1990;34:
385-392.
59. Vick WW, Wikstrand CJ, Bullard DE,
et al. The use of a panel of monoclonal
antibodies in the evaluation of cytologic
specimens from the central nervous
system.
Acta Cytol
1987;31:
815-824.
60. Gould VE, Jansson DS, Molenaar WM,
et al. Primitive neuroectodermal tumors of
the central nervous system: Patterns
of expression of neuroendocrine
markers and all classes of intermediate
filament proteins.
Lab Invest
1990;62:
498-508.
453
previous page 448 ComprehensiveCytopathology 1104p 2008 read online next page 450 ComprehensiveCytopathology 1104p 2008 read online Home Toggle text on/off